This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1994, Alexandria Real Estate Equities, Inc. is a Pasadena, CA-based urban office real estate investment trust (REIT) with particular focus on collaborative life science, agtech and technology campuses. The company’s assets are located in the AAA innovation cluster locations of North America, with considerable market presence in Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. The company enjoys a solid 10-year historical occupancy rate of 96% at operating properties in North America.
Prologis (PLD) Meets Q1 FFO Estimates, Trims 2024 Guidance
by Zacks Equity Research
While Prologis (PLD) puts up a decent show in the first quarter, it trims its 2024 outlook as it prepares for a slower leasing environment in the next quarter or two.
Alexandria (ARE) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
While Alexandria's (ARE) Q1 earnings are likely to have benefited from the healthy demand for its high-quality life science and lab office properties, high interest expenses raise concern.
Unveiling Alexandria Real Estate Equities (ARE) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alexandria Real Estate Equities (ARE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Is it Wise to Retain Ventas (VTR) Stock in Your Portfolio?
by Zacks Equity Research
A favorable demand in senior housing, backed by an expected rise in senior citizens' population is likely to support Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.
Should Investors Retain Healthpeak (DOC) Stock for Now?
by Zacks Equity Research
Solid demand for lab assets and rising healthcare expenditure by senior citizens bode well for Healthpeak (DOC). However, competition from peers and high interest rates are woes.
Here's Why Alexandria (ARE) Is an Apt Portfolio Pick for Now
by Zacks Equity Research
Robust demand for Alexandria's (ARE) high-quality life science and lab office properties in key markets, healthy operating performance and expansion efforts bode well for long-term growth.
Alexandria Real Estate Equities (ARE) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Alexandria (ARE) Sees Demand, Seals Early Renewal With insitro
by Zacks Equity Research
Alexandria's (ARE) securing of an early renewal with insitro for a six-year lease extension at the Alexandria Center for Advanced Technologies highlights the solid demand for its mega campus.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Why Alexandria Real Estate Equities (ARE) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Alexandria (ARE) Announces Lease Extension at Kendall Square
by Zacks Equity Research
Alexandria's (ARE) securing of renewal and lease extension with Takeda at Kendall Square in Cambridge highlights solid demand for its mega campus.
Why Alexandria Real Estate Equities (ARE) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Ventas' (VTR) Q4 FFO Meets Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves across the portfolio. It has also issued its 2024 outlook.
Welltower (WELL) Q4 FFO Beat Estimates, SHO Occupancy Rises
by Zacks Equity Research
Welltower's (WELL) Q4 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year.
Healthpeak's (PEAK) Q4 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (PEAK) Q4 results outshine estimates on better-than-anticipated revenues. Same-store cash NOI for the total portfolio improves year over year. It has issued its 2024 outlook.
Cousins Properties (CUZ) Q4 FFO Meets Mark, '24 View Issued
by Zacks Equity Research
Cousins Properties' (CUZ) Q4 FFO per share meets expectations. The top line improves year over year. It has issued its 2024 outlook for FFO per share.
Alexandria Real Estate Equities (ARE) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Rayonier (RYN) Q4 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Rayonier's (RYN) Q4 earnings meet estimates despite lower-than-anticipated revenues. The pro forma operating income declines in most segments excluding Real Estate. It has issued its 2024 outlook.
Boston Properties (BXP) Q4 FFO & Revenues Top, '24 View Issued
by Zacks Equity Research
Boston Properties' (BXP) Q4 results outshine estimates on better-than-anticipated revenues, aided by solid leasing activity. It issues its guidance for 2024 FFO per share.